CYTORI THERAPEUTICS, INC. | 2013 | FY | 3


The warrants were not traded in an active securities market, and as such, we estimated the fair value of these warrants using an option pricing model with the following assumptions:
 
 
 
As of
December 31, 2012
 
Expected term
 
0.61 years
 
Common stock market price
 
$
2.80
 
Risk-free interest rate
  
0.11
%
Expected volatility
  
73.88
%
Resulting fair value (per warrant)
 
$
0.20
 

us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock